This study systematically evaluated the biological activities of grapefruit (Citrus paradisi) extract following biotransformation by Leuconostoc mesenteroides CJNU 0147, with particular focus on its antimicrobial, anti-inflammatory, anticancer, and wo...
This study systematically evaluated the biological activities of grapefruit (Citrus paradisi) extract following biotransformation by Leuconostoc mesenteroides CJNU 0147, with particular focus on its antimicrobial, anti-inflammatory, anticancer, and wound-healing properties. After fermentation, the grapefruit extract was fractionated and assessed for antimicrobial efficacy against the pathogenic microorganisms Staphylococcus aureus and Candida albicans. In addition, its effects on cell proliferation and wound repair were examined using human keratinocyte (HaCaT) models, while cytotoxic and anticancer activities were evaluated in human colon cancer (HT-29) cells. The biotransformed grapefruit extracts exhibited significantly enhanced antimicrobial activity compared with non-fermented extracts. In HaCaT cells, treatment with the fermented extract promoted cellular proliferation and markedly accelerated wound closure, achieving complete healing within 24 h. Selective cytotoxicity toward HT-29 cells was observed, with stronger growth inhibition at 500 µg/mL than at 1000 µg/mL, indicating a dose-dependent but non-linear response. Furthermore, the biotransformed extract demonstrated notable anti-inflammatory effects, as evidenced by the downregulation of pro-inflammatory cytokines IL-1β and TNF-α. Overall, these findings demonstrate that L. mesenteroides–mediated biotransformation significantly enhances the biofunctional properties of grapefruit extract, highlighting its promising potential for application in nutraceutical and cosmeceutical formulations.